MacroGenics-Logo-(transparent-background).png
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
March 22, 2023 13:22 ET | MacroGenics, Inc.
ROCKVILLE, MD, March 22, 2023 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for...
dfds-logo-2021-group-blue-rgb.png
KØB AF MCBURNEY GODKENDT
February 23, 2023 06:24 ET | DFDS A/S
SELSKABSMEDDELELSE nr. 09 - 23. februar 2023  Den 29. december 2022 offentliggjorde DFDS, at der var indgået en aftale om at købe 100% af McBurney Transport Group. Gennemførsel af transaktionen var...
dfds-logo-2021-group-blue-rgb.png
ACQUISITION OF MCBURNEY APPROVED
February 23, 2023 06:24 ET | DFDS A/S
COMPANY ANNOUNCEMENT no. 09 - 23 February 2023  On 29 December 2022, DFDS announced it had entered into an agreement to acquire 100% of McBurney Transport Group. Completion of the acquisition was...
Logo-uniQure-MS-Word_Orange.jpg
uniQure announces the European Commission approval of the first gene therapy for adults with hemophilia B
February 21, 2023 07:05 ET | uniQure Inc.
~ Historic approval represents the first gene therapy in Europe to treat hemophilia B and provides a new treatment option for patients that reduces the rate of annual bleeds, reduces or eliminates the...
July 30, 2021 - ROSEN LOGO.jpg
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
February 14, 2023 20:40 ET | The Rosen Law Firm PA
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Phathom...
uniQure_facilityLEX
uniQure announces FDA approval of first gene therapy for adults with hemophilia B
November 22, 2022 16:40 ET | uniQure Inc.
~ Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX...
Chardan Logo.png
Chardan NexTech Acquisition 2 Corp. Shareholders Approve Previously Announced Business Combination with Dragonfly Energy, Corp.
October 06, 2022 16:05 ET | Dragonfly Energy Corp.
RENO, Nev., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Chardan NexTech Acquisition 2 Corp. (“CNTQ”) (Nasdaq: CNTQ), a publicly traded special purpose acquisition company, today announced that its...
ECC-1C-final choice_reduced.jpg
Ero Copper's Board of Directors Approves Construction of Boa Esperança Project
February 15, 2022 08:00 ET | Ero Copper Corp.
(all amounts in US dollars, unless otherwise noted) VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to...
July 30, 2021 - ROSEN LOGO.jpg
ALF LOSS ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Alfi, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ALF
December 07, 2021 10:31 ET | The Rosen Law Firm PA
NEW YORK, Dec. 07, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Alfi,...
July 30, 2021 - ROSEN LOGO.jpg
OWLT NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Owlet, Inc. Investors to Inquire About Class Action Investigation – OWLT
October 19, 2021 17:19 ET | The Rosen Law Firm PA
NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Owlet, Inc....